[1]
Rossini, M. et al. 2015. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?. Reumatismo. 66, 4 (Mar. 2015), 285–303. DOI:https://doi.org/10.4081/reumatismo.2014.799.